Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
65 years Old
100%
95% Confidence Interval
33%
Advanced Oropharyngeal Carcinoma
100%
Antiemetic Therapy
11%
Antiemetics
11%
Carboplatin
88%
CDDP
100%
Cetuximab
77%
Charlson Comorbidity Index
11%
Chemotherapy Regimen
100%
Cisplatin
11%
Comorbidity Index
11%
Comparative Efficacy
11%
Concurrent Chemoradiation
11%
Concurrent Chemotherapy
100%
Cox Proportional Hazards Model
11%
Dehydration
11%
Diarrhea
11%
Disease Profile
11%
Emesis
11%
Hazard Ratio
33%
High-risk Comorbidities
11%
Hospital Visits
22%
Human Papillomavirus
11%
Locally Advanced
100%
Mortality Costs
11%
Multivariate Model
11%
Nausea
11%
Non-white
11%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
22%
Overall Cost
22%
Overall Survival
33%
Patient Profile
11%
Pneumonia
11%
Selection Bias
11%
Statistically Significant Difference
11%
Strong Selection
11%
Surveillance Epidemiology
11%
Visit Rate
11%
Medicine and Dentistry
Antiemetic
25%
Carboplatin
100%
Cetuximab
87%
Charlson Comorbidity Index
12%
Chemoradiotherapy
12%
Chemotherapy
100%
Cisplatin
12%
Cohort Effect
12%
Comorbidity
12%
Diarrhea
12%
Diseases
12%
Hazard Ratio
37%
Health Care Cost
25%
Nausea
12%
Oropharynx Carcinoma
100%
Oropharynx Squamous Cell Carcinoma
12%
Overall Survival
37%
Pneumonia
12%
Proportional Hazards Model
12%
Selection Bias
12%
Wart Virus
12%
Pharmacology, Toxicology and Pharmaceutical Science
Antiemetic Agent
25%
Carboplatin
100%
Cetuximab
87%
Chemoradiation Therapy
12%
Chemotherapy Regimens
100%
Cisplatin
12%
Comorbidity
25%
Diarrhea
12%
Diseases
12%
Epidemiology
12%
Human Papillomavirus
12%
Nausea
12%
Oropharynx Cancer
12%
Oropharynx Carcinoma
100%
Oropharynx Squamous Cell Carcinoma
12%
Overall Survival
37%
Pneumonia
12%